Équipe
Elizabeth Cohen-Jonathan Moyal

RADOPT :

Optimisation de la radiothérapie: des voies de signalisation moléculaires aux essais cliniques

LES FOCUS
DE L’ÉQUIPE

En live

Voir plus

PRODUCTIONS SCIENTIFIQUES

PUBLICATIONS 2024
Bouly, Lucie, Lisa Jacquin, Florian Chapeau, Jean-Marc Bonmatin, Myriam Cousseau, Aurianne Hagimont, Pascal Laffaille, et al. “Fluopyram SDHI Pesticide Alters Fish Physiology and Behaviour despite Low in Vitro Effects on Mitochondria.” Ecotoxicology and Environmental Safety 288 (December 2024): 117400. https://doi.org/10.1016/j.ecoenv.2024.117400.
Modesto, Anouchka, Audrey Keller, Rosine Guimbaud, and Véronique Vendrely. “[Practice-changing clinical trials in gastrointestinal radiation oncology].” Cancer Radiotherapie: Journal De La Societe Francaise De Radiotherapie Oncologique, October 18, 2024, S1278-3218(24)00151-3. https://doi.org/10.1016/j.canrad.2024.09.004.
Figarella-Branger, Domique, Carole Colin, Karima Mokhtari, Emmanuelle Uro-Coste, Ahmed Idbaih, Romain Appay, Emeline Tabouret, et al. “Reappraisal of Prognostic Factors in CNS WHO Grade 3 Oligodendrogliomas IDH-Mutant and 1p/19q Co-Deleted: Lessons from the French POLA Cohort.” Neuro-Oncology, October 21, 2024, noae221. https://doi.org/10.1093/neuonc/noae221.
Tauziède-Espariat, Arnault, Azadeh Ebrahimi, Nathalie Boddaert, Torsten Pietsch, Wieslawa Grajkowska, Tobias Blau, Arend Koch, et al. “CIC/ATXN1-Rearranged Tumors in the Central Nervous System Are Mainly Represented by Sarcomas: A Comprehensive Clinicopathological and Epigenetic Series.” Brain Pathology (Zurich, Switzerland), October 23, 2024, e13303. https://doi.org/10.1111/bpa.13303.
Baudry, Guillaume, Marco Metra, and Clément Delmas. “Are Mechanical Circulatory Supports the Forgotten Aspect in the Implementation of Therapies for Heart Failure?” European Journal of Heart Failure, August 15, 2024. https://doi.org/10.1002/ejhf.3422.
Le Quang, Mégane, Aude Trinquet, Aurore Siegfried, Amaury de Barros, Luc Bauchet, Sam Ng, Vincent Jecko, et al. “FGFR1 Wild-Type Rosette-Forming Glioneuronal Tumours.” Acta Neuropathologica 148, no. 1 (August 21, 2024): 26. https://doi.org/10.1007/s00401-024-02779-x.
Picca, Alberto, Mehdi Touat, Lisa Belin, Carole Gourmelon, Vincent Harlay, Stefania Cuzzubbo, Elizabeth Cohen-Jonathan Moyal, et al. “REVOLUMAB: A Phase II Trial of Nivolumab in Recurrent IDH Mutant High-Grade Gliomas.” European Journal of Cancer (Oxford, England: 1990) 202 (May 2024): 114034. https://doi.org/10.1016/j.ejca.2024.114034.
Sakata, Dousatsu, Ryoichi Hirayama, Wook-Geun Shin, Mauro Belli, Maria A. Tabocchini, Robert D. Stewart, Oleg Belov, et al. “Corrigendum to ‘Prediction of DNA Rejoining Kinetics and Cell Survival after Proton Irradiation for V79 Cells Using Geant4-DNA’ [Phys. Med. 105 (2023) 102508].” Physica Medica: PM: An International Journal Devoted to the Applications of Physics to Medicine and Biology: Official Journal of the Italian Association of Biomedical Physics (AIFB), May 15, 2024, 103375. https://doi.org/10.1016/j.ejmp.2024.103375.
Tauziède-Espariat, Arnault, Yvan Nicaise, Philipp Sievers, Felix Sahm, Andreas von Deimling, Delphine Guillemot, Gaëlle Pierron, et al. “CNS Tumors with PLAGL1-Fusion: Beyond ZFTA and YAP1 in the Genetic Spectrum of Supratentorial Ependymomas.” Acta Neuropathologica Communications 12, no. 1 (April 5, 2024): 55. https://doi.org/10.1186/s40478-023-01695-7.
Laprie, Anne, Georges Noel, Leonor Chaltiel, Gilles Truc, Marie-Pierre Sunyach, Marie Charissoux, Nicolas Magne, et al. “Randomized Phase III Trial of Metabolic Imaging-Guided Dose Escalation of Radio-Chemotherapy in Patients with Newly Diagnosed Glioblastoma (SPECTRO GLIO Trial).” Neuro-Oncology 26, no. 1 (January 5, 2024): 153–63. https://doi.org/10.1093/neuonc/noad119.
PUBLICATIONS 2023
Uro-Coste, Emmanuelle, Arnault Tauziede-Espariat, Charlotte Dubucs, Dan Christian Chiforeanu, Aurore Siegfried, Yvan Nicaise, Luc Bauchet, et al. “Two Novel Tumours with NTRK2 Fusion in the Methylation Class of Extraventricular Neurocytomas, Including One Intraventricular.” Brain Pathology (Zurich, Switzerland), November 23, 2023, e13223. https://doi.org/10.1111/bpa.13223.
Younes, Tony, Frédéric Chatrie, Marianne Zinutti, Luc Simon, Georges Fares, and Laure Vieillevigne. “Optimization of the Eclipse TPS Beam Configuration Parameters for Small Field Dosimetry Using Monte Carlo Simulations and Experimental Measurements.” Physica Medica: PM: An International Journal Devoted to the Applications of Physics to Medicine and Biology: Official Journal of the Italian Association of Biomedical Physics (AIFB) 114 (October 2023): 103141. https://doi.org/10.1016/j.ejmp.2023.103141.
Hardcastle, Nicholas, Mirjana Josipovic, Enrico Clementel, Victor Hernandez, Gregory Smyth, Manuela Gober, Lotte Wilke, et al. “Recommendation on the Technical and Dosimetric Data to Be Included in Stereotactic Body Radiation Therapy Clinical Trial Publications Based on a Systematic Review.” Radiotherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology 190 (December 1, 2023): 110042. https://doi.org/10.1016/j.radonc.2023.110042.
Tauziède-Espariat, Arnault, Emmanuelle Uro-Coste, Yvan Nicaise, Philipp Sievers, Andreas von Deimling, Felix Sahm, Oumaima Aboubakr, Alice Métais, Fabrice Chrétien, and Pascale Varlet. “Refinement of Diagnostic Criteria for Pediatric-Type Diffuse High-Grade Glioma, IDH- and H3-Wildtype, MYCN-Subtype Including Histopathology, TP53, MYCN and ID2 Status.” Acta Neuropathologica Communications 11, no. 1 (October 24, 2023): 170. https://doi.org/10.1186/s40478-023-01667-x.
Modesto, Anouchka, David Tougeron, Pierre Tremolières, Philippe Ronchin, Ariane Darut Jouve, Delphine Argo Leignel, Véronique Vendrely, et al. “Association of Radiochemotherapy to Immunotherapy in Unresectable Locally Advanced Oesophageal CarciNoma-Randomized Phase 2 Trial ARION UCGI 33/PRODIGE 67: The Study Protocol.” BMC Cancer 23, no. 1 (October 12, 2023): 966. https://doi.org/10.1186/s12885-023-11227-0.
Robinet, Lucas, Aurore Siegfried, Margaux Roques, Ahmad Berjaoui, and Elizabeth Cohen-Jonathan Moyal. “MRI-Based Deep Learning Tools for MGMT Promoter Methylation Detection: A Thorough Evaluation.” Cancers 15, no. 8 (April 12, 2023): 2253. https://doi.org/10.3390/cancers15082253.
Gilhodes, Julia, Adèle Meola, Bastien Cabarrou, Guillaume Peyraga, Caroline Dehais, Dominique Figarella-Branger, François Ducray, et al. “A Multigene Signature Associated with Progression-Free Survival after Treatment for IDH Mutant and 1p/19q Codeleted Oligodendrogliomas.” Cancers 15, no. 12 (June 6, 2023): 3067. https://doi.org/10.3390/cancers15123067.
Khalifa, Jonathan, Noémie Thébault, Clara-Maria Scarlata, Emma Norkowski, Carole Massabeau, Laurent Brouchet, Sophie Peries Bataille, et al. “Immune Changes in Hilar Tumor Draining Lymph Nodes Following Node Sparing Neoadjuvant Chemoradiotherapy of Localized CN0 Non-Small Cell Lung Cancer.” Frontiers in Oncology 13 (2023): 1269166. https://doi.org/10.3389/fonc.2023.1269166.
Cartiaux, Benjamin, Alexandra Deviers, Caroline Delmas, Jérôme Abadie, Martí Pumarola Battle, Elizabeth Cohen-Jonathan Moyal, and Giovanni Mogicato. “Evaluation of in Vitro Intrinsic Radiosensitivity and Characterization of Five Canine High-Grade Glioma Cell Lines.” Frontiers in Veterinary Science 10 (2023): 1253074. https://doi.org/10.3389/fvets.2023.1253074.
Bentaberry-Rosa, Alexandre, Yvan Nicaise, Caroline Delmas, Valérie Gouazé-Andersson, Elizabeth Cohen-Jonathan-Moyal, and Catherine Seva. “Overexpression of Growth Differentiation Factor 15 in Glioblastoma Stem Cells Promotes Their Radioresistance.” Cancers 16, no. 1 (December 20, 2023): 27. https://doi.org/10.3390/cancers16010027.
Huguet, F., O. Riou, D. Pasquier, A. Modesto, L. Quéro, M. Michalet, A. Bordron, et al. “Radiation Therapy of the Primary Tumour and/or Metastases of Digestive Metastatic Cancers.” Cancer Radiotherapie: Journal De La Societe Francaise De Radiotherapie Oncologique, October 6, 2023, S1278-3218(23)00209-3. https://doi.org/10.1016/j.canrad.2023.04.007.
Lemarié, Anthony, Vincent Lubrano, Caroline Delmas, Amélie Lusque, Juan-Pablo Cerapio, Marion Perrier, Aurore Siegfried, et al. “The STEMRI Trial: Magnetic Resonance Spectroscopy Imaging Can Define Tumor Areas Enriched in Glioblastoma Stem-like Cells.” Science Advances 9, no. 44 (November 3, 2023): eadi0114. https://doi.org/10.1126/sciadv.adi0114.
Darréon, J., C. Massabeau, C. Geffroy, P. Maroun, and L. Simon. “Surface-Guided Radiotherapy Overview: Technical Aspects and Clinical Applications.” Cancer Radiotherapie: Journal De La Societe Francaise De Radiotherapie Oncologique 27, no. 6–7 (September 2023): 504–10. https://doi.org/10.1016/j.canrad.2023.07.003.
Pouessel, Damien, Soléakhéna Ken, Valérie Gouaze-Andersson, Lucie Piram, Augustin Mervoyer, Delphine Larrieu-Ciron, Bastien Cabarrou, et al. “Hypofractionated Stereotactic Re-Irradiation and  Anti-PDL1 Durvalumab Combination in Recurrent Glioblastoma: STERIMGLI Phase I Results.” The Oncologist 28, no. 9 (September 7, 2023): 825-e817. https://doi.org/10.1093/oncolo/oyad095.
Prat, Mélissa, Kimberley Coulson, Clément Blot, Godefroy Jacquemin, Mathilde Romano, Marie-Laure Renoud, Mohamad AlaEddine, et al. “PPARγ Activation Modulates the Balance of Peritoneal Macrophage Populations to Suppress Ovarian Tumor Growth and Tumor-Induced Immunosuppression.” Journal for Immunotherapy of Cancer 11, no. 8 (August 2023): e007031. https://doi.org/10.1136/jitc-2023-007031.
Tensaouti, Fatima, Franck Desmoulin, Julia Gilhodes, Margaux Roques, Soleakhena Ken, Jean-Albert Lotterie, Georges Noël, et al. “Is Pre-Radiotherapy Metabolic Heterogeneity of Glioblastoma Predictive of Progression-Free Survival?” Radiotherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology 183 (June 2023): 109665. https://doi.org/10.1016/j.radonc.2023.109665.
Hernández-Verdin, I., E. Kirasic, K. Wienand, K. Mokhtari, S. Eimer, H. Loiseau, A. Rousseau, et al. “Molecular and Clinical Diversity in Primary Central Nervous System Lymphoma.” Annals of Oncology: Official Journal of the European Society for Medical Oncology 34, no. 2 (February 2023): 186–99. https://doi.org/10.1016/j.annonc.2022.11.002.
Tauziède-Espariat, Arnault, Emmanuelle Uro-Coste, Philipp Sievers, Yvan Nicaise, Cassandra Mariet, Aurore Siegfried, Gaëlle Pierron, et al. “CNS Tumor with EP300::BCOR Fusion: Discussing Its Prevalence in Adult Population.” Acta Neuropathologica Communications 11, no. 1 (February 13, 2023): 26. https://doi.org/10.1186/s40478-023-01523-y.
Aboudaram, Amélie, Léonor Chaltiel, Damien Pouessel, Pierre Graff-Cailleaud, Nicolas Benziane-Ouaritini, Paul Sargos, Ulrike Schick, et al. “Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients with No Progression and with No More than Five Residual Metastatic Lesions Following First-Line Systemic Therapy: A Retrospective Analysis.” Cancers 15, no. 4 (February 11, 2023): 1161. https://doi.org/10.3390/cancers15041161.
Sakata, Dousatsu, Ryoichi Hirayama, Wook-Geun Shin, Mauro Belli, Maria A. Tabocchini, Robert D. Stewart, Oleg Belov, et al. “Prediction of DNA Rejoining Kinetics and Cell Survival after Proton Irradiation for V79 Cells Using Geant4-DNA.” Physica Medica: PM: An International Journal Devoted to the Applications of Physics to Medicine and Biology: Official Journal of the Italian Association of Biomedical Physics (AIFB) 105 (January 2023): 102508. https://doi.org/10.1016/j.ejmp.2022.11.012.
Métais, Alice, Yassine Bouchoucha, Thomas Kergrohen, Volodia Dangouloff-Ros, Xavier Maynadier, Yassine Ajlil, Matthieu Carton, et al. “Pediatric Spinal Pilocytic Astrocytomas Form a Distinct Epigenetic Subclass from Pilocytic Astrocytomas of Other Locations and Diffuse Leptomeningeal Glioneuronal Tumours.” Acta Neuropathologica 145, no. 1 (January 2023): 83–95. https://doi.org/10.1007/s00401-022-02512-6.
PUBLICATIONS 2022
Modesto, A., P. Graff Cailleaud, P. Blanchard, P. Boisselier, and Y. Pointreau. “[Challenges and limits of therapeutic de-escalation for papillomavirus-related oropharyngeal cancer].” Cancer Radiotherapie: Journal De La Societe Francaise De Radiotherapie Oncologique 26, no. 6–7 (October 2022): 921–24. https://doi.org/10.1016/j.canrad.2022.06.018.
Bikfalvi, Andreas, Cristine Alves da Costa, Tony Avril, Jean-Vianney Barnier, Luc Bauchet, Lucie Brisson, Pierre Francois Cartron, et al. “Challenges in Glioblastoma Research: Focus on the Tumor Microenvironment.” Trends in Cancer, November 15, 2022, S2405-8033(22)00220-5. https://doi.org/10.1016/j.trecan.2022.09.005.
Ouvrard, Chloé, Alice Métais, Enola Brigot, Charlotte Berthaud, Noémie Pucelle, Joëlle Lacombe, Lauren Hasty, et al. “ETV4 Immunohistostaining Is a Sensitive and Specific Diagnostic Biomarker for CIC-Rearranged Sarcoma of the Central Nervous System.” Histopathology 81, no. 6 (December 2022): 852–55. https://doi.org/10.1111/his.14796.
Tauziède-Espariat, Arnault, null Volodia-Dangouloff-Ros, Dominique Figarella-Branger, Emmanuelle Uro-Coste, Yvan Nicaise, Nicolas André, Didier Scavarda, et al. “Clinicopathological and Molecular Characterization of Three Cases Classified by DNA-Methylation Profiling as ‘Glioneuronal Tumors, NOS, Subtype A.’” Acta Neuropathologica 144, no. 6 (December 2022): 1179–83. https://doi.org/10.1007/s00401-022-02490-9.
Tauziède-Espariat, Arnault, Aurore Siegfried, Yvan Nicaise, Dominique Figarella-Branger, Romain Appay, Suhan Senova, Dorian Bochaton, et al. “A Novel YAP1-MAML2 Fusion in an Adult Supra-Tentorial Ependymoma, YAP1-Fused.” Brain Tumor Pathology, October 2022. https://doi.org/10.1007/s10014-022-00439-0.
Laprie, A., F. Tensaouti, and E. Cohen-Jonathan Moyal. “[Radiation dose intensification for glioblastoma].” Cancer Radiotherapie: Journal De La Societe Francaise De Radiotherapie Oncologique 26, no. 6–7 (October 2022): 894–98. https://doi.org/10.1016/j.canrad.2022.07.007.
Appay, Romain, Franck Bielle, Philipp Sievers, Doriane Barets, Frédéric Fina, Jean Boutonnat, Adam Clovis, et al. “Rosette-Forming Glioneuronal Tumours Are Midline, FGFR1-Mutated Tumours.” Neuropathology and Applied Neurobiology, March 16, 2022, e12813. https://doi.org/10.1111/nan.12813.
Maingon, P., V. Marchesi, D. Azria, J. Balosso, É Deutsch, É Cohen Jonathan-Moyal, P. Giraud, and É Bayart. “RadioTransNet: Preclinical Research Network Coordinated at the SFRO and SFPM.” Cancer Radiotherapie: Journal De La Societe Francaise De Radiotherapie Oncologique 26, no. 1–2 (April 2022): 108–15. https://doi.org/10.1016/j.canrad.2021.08.003.
Sidibe, Ingrid, Fatima Tensaouti, Margaux Roques, Elizabeth Cohen-Jonathan-Moyal, and Anne Laprie. “Pseudoprogression in Glioblastoma: Role of Metabolic and Functional MRI-Systematic Review.” Biomedicines 10, no. 2 (January 26, 2022): 285. https://doi.org/10.3390/biomedicines10020285.
Métais, Alice, Romain Appay, Mélanie Pagès, Catherine Gallardo, Karen Silva, Aurore Siegfried, Romain Perbet, et al. “Low-Grade Epilepsy-Associated Neuroepithelial Tumours with a Prominent Oligodendroglioma-like Component: The Diagnostic Challenges.” Neuropathology and Applied Neurobiology 48, no. 2 (February 2022): e12769. https://doi.org/10.1111/nan.12769.
Hennequin, C., D. Azria, P. Blanchard, G. Créhange, É Deutsch, A. Lisbona, É Moyal, et al. “Specificities of Clinical Research in Radiotherapy.” Cancer Radiotherapie: Journal De La Societe Francaise De Radiotherapie Oncologique 26, no. 1–2 (April 2022): 104–7. https://doi.org/10.1016/j.canrad.2021.11.011.
Monteiro, Cátia, Lauritz Miarka, María Perea-García, Neibla Priego, Pedro García-Gómez, Laura Álvaro-Espinosa, Ana de Pablos-Aragoneses, et al. “Stratification of Radiosensitive Brain Metastases Based on an Actionable S100A9/RAGE Resistance Mechanism.” Nature Medicine, April 11, 2022. https://doi.org/10.1038/s41591-022-01749-8.
Garnier, Louis, Chrystelle Vidal, Olivier Chinot, Elisabeth Cohen-Jonathan Moyal, Apolline Djelad, Charlotte Bronnimann, Lien Bekaert, et al. “Characteristics of Anaplastic Oligodendrogliomas Short-Term Survivors: A POLA Network Study.” The Oncologist 27, no. 5 (May 6, 2022): 414–23. https://doi.org/10.1093/oncolo/oyac023.
Tauziède-Espariat, Arnault, Philipp Sievers, Frédérique Larousserie, Joseph Benzakoun, Delphine Guillemot, Gaëlle Pierron, Mathilde Duchesne, et al. “An Integrative Histopathological and Epigenetic Characterization of Primary Intracranial Mesenchymal Tumors, FET:CREB-Fused Broadening the Spectrum of Tumor Entities in Comparison with Their Soft Tissue Counterparts.” Brain Pathology (Zurich, Switzerland) 32, no. 1 (January 2022): e13010. https://doi.org/10.1111/bpa.13010.
Lacore, Marie Geraldine, Caroline Delmas, Yvan Nicaise, Aline Kowalski-Chauvel, Elizabeth Cohen-Jonathan-Moyal, and Catherine Seva. “The Glycoprotein M6a Is Associated with Invasiveness and Radioresistance of Glioblastoma Stem Cells.” Cells 11, no. 14 (July 6, 2022): 2128. https://doi.org/10.3390/cells11142128.
Tauziède-Espariat, Arnault, Aurore Siegfried, Emmanuelle Uro-Coste, Yvan Nicaise, David Castel, Annick Sevely, Marion Gambart, et al. “Disseminated Diffuse Midline Gliomas, H3K27-Altered Mimicking Diffuse Leptomeningeal Glioneuronal Tumors: A Diagnostical Challenge!” Acta Neuropathologica Communications 10, no. 1 (August 19, 2022): 119. https://doi.org/10.1186/s40478-022-01419-3.
Duval, Tanguy, Jean-Albert Lotterie, Anthony Lemarie, Caroline Delmas, Fatima Tensaouti, Elizabeth Cohen-Jonathan Moyal, and Vincent Lubrano. “Glioblastoma Stem-like Cell Detection Using Perfusion and Diffusion MRI.” Cancers 14, no. 11 (June 4, 2022): 2803. https://doi.org/10.3390/cancers14112803.
Tensaouti, Fatima, Franck Desmoulin, Julia Gilhodes, Elodie Martin, Soleakhena Ken, Jean-Albert Lotterie, Georges Noël, et al. “Quality Control of 3D MRSI Data in Glioblastoma: Can We Do without the Experts?” Magnetic Resonance in Medicine 87, no. 4 (April 2022): 1688–99. https://doi.org/10.1002/mrm.29098.
Acquitter, Clément, Lucie Piram, Umberto Sabatini, Julia Gilhodes, Elizabeth Moyal Cohen-Jonathan, Soleakhena Ken, and Benjamin Lemasson. “Radiomics-Based Detection of Radionecrosis Using Harmonized Multiparametric MRI.” Cancers 14, no. 2 (January 7, 2022): 286. https://doi.org/10.3390/cancers14020286.
Balosso, J., F. Missohou, D. Antoni, C. Hennequin, M.-A. Mahé, L. Simon, and C. Demoor-Goldschmidt. “Radiotherapy of Lymphomas.” Cancer/Radiothérapie 26, no. 1–2 (2022): 388–96. https://doi.org/10.1016/j.canrad.2021.11.007.
Darréon, J., G. Bouilhol, N. Aillières, H. Bouscayrol, L. Simon, and M. Ayadi. “Respiratory Motion Management for External Radiotherapy Treatment.” Cancer/Radiothérapie 26, no. 1–2 (2022): 50–58. https://doi.org/10.1016/j.canrad.2021.09.006.
Grégoire, V., P. Giraud, L. Vieillevigne, and P. Maingon. “Management of Oropharyngeal Squamous Cell Carcinoma.” Cancer Radiotherapie: Journal De La Societe Francaise De Radiotherapie Oncologique 26, no. 1–2 (April 2022): 174–88. https://doi.org/10.1016/j.canrad.2021.10.002.
Grégoire, V., S. Boisbouvier, P. Giraud, P. Maingon, Y. Pointreau, and L. Vieillevigne. “Management and Work-up Procedures of Patients with Head and Neck Malignancies Treated by Radiation.” Cancer Radiotherapie: Journal De La Societe Francaise De Radiotherapie Oncologique 26, no. 1–2 (April 2022): 147–55. https://doi.org/10.1016/j.canrad.2021.10.005.
Delbaere, Alexia, Tony Younes, Luc Simon, Catherine Khamphan, and Laure Vieillevigne. “Field Output Correction Factors and Electron Fluence Perturbation of the MicroSilicon and MicroSilicon X Detectors.” Physics in Medicine and Biology 67, no. 8 (April 7, 2022). https://doi.org/10.1088/1361-6560/ac5e5e.
Deshors, Pauline, Florent Arnauduc, Betty Boëlle, Elizabeth Cohen-Jonathan Moyal, Monique Courtade-Saïdi, and Solène M. Evrard. “Impact of Regorafenib on Endothelial Transdifferentiation of Glioblastoma Stem-like Cells.” Cancers 14, no. 6 (March 18, 2022): 1551. https://doi.org/10.3390/cancers14061551.
PUBLICATIONS 2021
Zanca, F., I. Hernandez-Giron, M. Avanzo, G. Guidi, W. Crijns, O. Diaz, G. C. Kagadis, et al. “Expanding the Medical Physicist Curricular and Professional Programme to Include Artificial Intelligence.” Physica Medica: PM: An International Journal Devoted to the Applications of Physics to Medicine and Biology: Official Journal of the Italian Association of Biomedical Physics (AIFB) 83 (March 2021): 174–83. https://doi.org/10.1016/j.ejmp.2021.01.069.
Robert, C., A. Munoz, D. Moreau, J. Mazurier, G. Sidorski, A. Gasnier, G. Beldjoudi, et al. “Clinical Implementation of Deep-Learning Based Auto-Contouring Tools–Experience of Three French Radiotherapy Centers.” Cancer/Radiothérapie 25, no. 6–7 (2021): 607–16. https://doi.org/10.1016/j.canrad.2021.06.023.
Meyer, P., M.-C. Biston, C. Khamphan, T. Marghani, J. Mazurier, V. Bodez, L. Fezzani, et al. “Automation in Radiotherapy Treatment Planning: Examples of Use in Clinical Practice and Future Trends for a Complete Automated Workflow.” Cancer/Radiothérapie 25, no. 6–7 (2021): 617–22. https://doi.org/10.1016/j.canrad.2021.06.006.
Simon, L., C. Robert, and P. Meyer. “Artificial Intelligence for Quality Assurance in Radiotherapy.” Cancer/Radiothérapie 25, no. 6–7 (2021): 623–26. https://doi.org/10.1016/j.canrad.2021.06.012.
Leste, Jeremy, Tony Younes, Maxime Chauvin, Xavier Franceries, Alexia Delbaere, Laure Vieillevigne, Regis Ferrand, Manuel Bardies, and Luc Simon. “Technical Note: GAMMORA, a Free, Open-Source, and Validated GATE-Based Model for Monte-Carlo Simulations of the Varian TrueBeam.” Physica Medica 89 (2021): 211–18. https://doi.org/10.1016/j.ejmp.2021.07.037.
Attal, J., B. Cabarrou, T. Valentin, J. P. Nesseler, E. Stoeckle, A. Ducassou, T. Filleron, et al. “Evaluation of Two Modalities of Perioperative Treatment in the Management of Extremity and Truncal Soft Tissue Sarcomas: Neoadjuvant Concurrent Chemoradiotherapy and Sequential Treatment.” Strahlentherapie Und Onkologie: Organ Der Deutschen Rontgengesellschaft ... [et Al] 197, no. 12 (December 2021): 1051–62. https://doi.org/10.1007/s00066-021-01847-5.
Alhalabi, Karam T., Damian Stichel, Philipp Sievers, Heike Peterziel, Alexander C. Sommerkamp, Dominik Sturm, Andrea Wittmann, et al. “PATZ1 Fusions Define a Novel Molecularly Distinct Neuroepithelial Tumor Entity with a Broad Histological Spectrum.” Acta Neuropathologica 142, no. 5 (November 2021): 841–57. https://doi.org/10.1007/s00401-021-02354-8.
Sacko, Oumar, Alexandra Benouaich-Amiel, Pierre Brandicourt, Mahamadou Niaré, Saloua Charni, Clarissa Cavandoli, David Brauge, et al. “The Impact of Surgery on the Survival of Patients with Recurrent Glioblastoma.” Asian Journal of Neurosurgery 16, no. 1 (2021): 1–7. https://doi.org/10.4103/ajns.AJNS_180_20.
Dalmasso, Céline, Cécile Pagès, Léonor Chaltiel, Vincent Sibaud, Elisabeth Moyal, Ciprian Chira, Jean Christophe Sol, Igor Latorzeff, Nicolas Meyer, and Anouchka Modesto. “Intracranial Treatment in Melanoma Patients with Brain Metastasis Is Associated with Improved Survival in the Era of Immunotherapy and Anti-BRAF Therapy.” Cancers 13, no. 17 (2021): 4493. https://doi.org/10.3390/cancers13174493.
Roth, P., A. Pace, E. Le Rhun, M. Weller, C. Ay, E. Cohen-Jonathan Moyal, M. Coomans, et al. “Neurological and Vascular Complications of Primary and Secondary Brain Tumours: EANO-ESMO Clinical Practice Guidelines for Prophylaxis, Diagnosis, Treatment and Follow-Up.” Annals of Oncology: Official Journal of the European Society for Medical Oncology 32, no. 2 (2021): 171–82. https://doi.org/10.1016/j.annonc.2020.11.003.
Esteyrie, Vincent, Caroline Dehais, Elodie Martin, Catherine Carpentier, Emmanuelle Uro-Coste, Dominique Figarella-Branger, Charlotte Bronniman, et al. “Radiotherapy Plus Procarbazine, Lomustine, and Vincristine Versus Radiotherapy Plus Temozolomide for IDH-Mutant Anaplastic Astrocytoma: A Retrospective Multicenter Analysis of the French POLA Cohort.” The Oncologist 26, no. 5 (2021): e838–46. https://doi.org/10.1002/onco.13701.
Peyraga, G., A. Ducassou, F.-X. Arnaud, T. Lizée, J. Pouédras, and É Moyal. “[Radiotherapy and spinal toxicity: News and perspectives].” Cancer Radiotherapie: Journal De La Societe Francaise De Radiotherapie Oncologique 25, no. 1 (2021): 55–61. https://doi.org/10.1016/j.canrad.2020.05.017.
Picart, Thiébaud, Marc Barritault, Delphine Poncet, Lise-Prune Berner, Cristina Izquierdo, Emeline Tabouret, Dominique Figarella-Branger, et al. “Characteristics of Diffuse Hemispheric Gliomas, H3 G34-Mutant in Adults,” 2021.
Pinto, Giulia, Inés Saenz-de-Santa-Maria, Patricia Chastagner, Emeline Perthame, Caroline Delmas, Christine Toulas, Elizabeth Moyal-Jonathan-Cohen, Christel Brou, and Chiara Zurzolo. “Patient-Derived Glioblastoma Stem Cells Transfer Mitochondria through Tunneling Nanotubes in Tumor Organoids.” The Biochemical Journal 478, no. 1 (2021): 21–39. https://doi.org/10.1042/BCJ20200710.
Tauziède-Espariat, Arnault, Aurore Siegfried, Yvan Nicaise, Thomas Kergrohen, Philipp Sievers, Alexandre Vasiljevic, Alexandre Roux, et al. “Supratentorial Non-RELA, ZFTA-Fused Ependymomas: A Comprehensive Phenotype Genotype Correlation Highlighting the Number of Zinc Fingers in ZFTA-NCOA1/2 Fusions.” Acta Neuropathologica Communications 9, no. 1 (August 13, 2021): 135. https://doi.org/10.1186/s40478-021-01238-y.
Leste, Jeremy, Imene Medjahed, Maxime Chauvin, Tony Younes, Laure Vieillevigne, Regis Ferrand, Xavier Franceries, Manuel Bardies, and Luc Simon. “A Study of the Interplay Effect in Radiation Therapy Using a Monte-Carlo Model.” Physica Medica: PM: An International Journal Devoted to the Applications of Physics to Medicine and Biology: Official Journal of the Italian Association of Biomedical Physics (AIFB) 87 (July 2021): 73–82. https://doi.org/10.1016/j.ejmp.2021.05.019.
Younes, Tony, Maxime Chauvin, Alexia Delbaere, Joey Labour, Victoria Fonteny, Luc Simon, Georges Fares, and Laure Vieillevigne. “Towards the Standardization of the Absorbed Dose Report Mode in High Energy Photon Beams.” Physics in Medicine and Biology 66, no. 4 (February 2, 2021): 045009. https://doi.org/10.1088/1361-6560/abd22c.
Khalifa, Jonathan, Julien Mazieres, Carlos Gomez-Roca, Maha Ayyoub, and Elizabeth Cohen-Jonathan Moyal. “Radiotherapy in the Era of Immunotherapy With a Focus on Non-Small-Cell Lung Cancer: Time to Revisit Ancient Dogmas?” Frontiers in Oncology 11 (2021): 662236. https://doi.org/10.3389/fonc.2021.662236.
PUBLICATIONS 2020
Kowalski-Chauvel, Aline, Marie Géraldine Lacore, Florent Arnauduc, Caroline Delmas, Christine Toulas, Elizabeth Cohen-Jonathan-Moyal, and Catherine Seva. “The M6A RNA Demethylase ALKBH5 Promotes Radioresistance and Invasion Capability of Glioma Stem Cells.” Cancers 13, no. 1 (December 25, 2020): 40. https://doi.org/10.3390/cancers13010040.
Grossiord, Eloïse, Laurent Risser, Salim Kanoun, Richard Aziza, Harold Chiron, Loïc Ysebaert, François Malgouyres, and Soléakhéna Ken. “Semi-Automatic Segmentation of Whole-Body Images in Longitudinal Studies.” Biomedical Physics & Engineering Express 7, no. 1 (December 8, 2020). https://doi.org/10.1088/2057-1976/abce16.
Bertorello, Juliette, Julie Sesen, Julia Gilhodes, Solène Evrard, Monique Courtade-Saïdi, Meera Augustus, Emmanuelle Uro-Coste, et al. “Translation Reprogramming by EIF3 Linked to Glioblastoma Resistance.” NAR Cancer 2, no. 3 (September 2020): zcaa020. https://doi.org/10.1093/narcan/zcaa020.
Leste, Jermey, Imene Medjahed, François-Xavier Arnaud, Regis Ferrand, Xavier Franceries, Manuel Bardies, and Luc Simon. “A Study of the Interplay Effect for VMAT SBRT Using a Four-Axes Motion Phantom.” Journal of Applied Clinical Medical Physics, June 23, 2020. https://doi.org/10.1002/acm2.12947.
Ben Ahmed, Yassir, Jérémy Coulaud, Soléakhena Ken, and Laure Parent. “Determination of Paramagnetic Ferrous Gel Sensitivity in Low Energy X-Ray Beam Produced by a Miniature Accelerator.” Edited by Guillem Pratx. PLOS ONE 15, no. 5 (May 4, 2020): e0232315. https://doi.org/10.1371/journal.pone.0232315.
Gouazé-Andersson, Valérie, and Elizabeth Cohen-Jonathan Moyal. “New Avenues in Radiotherapy of Glioblastoma: From Bench to Bedside.” Current Treatment Options in Neurology 22, no. 12 (2020): 45. https://doi.org/10.1007/s11940-020-00654-0.
Dalmasso, Céline, Cécile Pagès, Léonor Chaltiel, Aurore Brun, Vincent Sibaud, Serge Boulinguez, Ciprian Chira, et al. “Survival Estimation of Melanoma Patients with Brain Metastasis Using the Melanoma-MolGPA Score: External Validation from a French Cohort.” Melanoma Research 30, no. 5 (2020): 472–76. https://doi.org/10.1097/CMR.0000000000000670.
De Barros, Amaury, Justine Attal, Margaux Roques, Julien Nicolau, Jean-Christophe Sol, Saloua Charni, Elizabeth Cohen-Jonathan-Moyal, and Franck-Emmanuel Roux. “Glioblastoma Survival Is Better Analyzed on Preradiotherapy MRI than on Postoperative MRI Residual Volumes: A Retrospective Observational Study.” Clinical Neurology and Neurosurgery 196 (2020): 105972. https://doi.org/10.1016/j.clineuro.2020.105972.
Cohen-Jonathan-Moyal, é., V. Vendrely, L. Motte, J. Balosso, and J. Thariat. “Radioresistant Tumours: From Identification to Targeting.” Cancer/Radiothérapie, 2020, S1278321820301669. https://doi.org/10.1016/j.canrad.2020.05.005.
Modesto, A., C. Dalmasso, A. Lusque, L. Vieillevigne, F. Izar, E. Moyal, N. Carrère, R. Guimbaud, and M. Rives. “Tolerance and Efficacy of Dose Escalation Using IMRT Combined with Chemotherapy for Unresectable Esophageal Carcinoma: Long-Term Results of 51 Patients.” Cancer/Radiothérapie 24, no. 2 (2020): 88–92. https://doi.org/10.1016/j.canrad.2020.01.006.
PUBLICATIONS 2019
Deshors, Pauline, Christine Toulas, Florent Arnauduc, Laure Malric, Aurore Siegfried, Yvan Nicaise, Anthony Lemarié, et al. “Ionizing Radiation Induces Endothelial Transdifferentiation of Glioblastoma Stem-like Cells through the Tie2 Signaling Pathway.” Cell Death & Disease 10, no. 11 (October 28, 2019): 816. https://doi.org/10.1038/s41419-019-2055-6.
Bayart, E., D. Azria, J. Balosso, M. Benderitter, E. Cohen-Jonathan Moyal, G. Delpon, E. Deutsch, et al. “[RadioTransNet, the French network for preclinical research in oncological radiotherapy].” Cancer Radiotherapie: Journal De La Societe Francaise De Radiotherapie Oncologique, August 24, 2019. https://doi.org/10.1016/j.canrad.2019.07.155.
Dauzier, Etienne, Benjamin Lacas, Pierre Blanchard, Quynh-Thu Le, Christian Simon, Gregory Wolf, François Janot, et al. “Role of Chemotherapy in 5000 Patients with Head and Neck Cancer Treated by Curative Surgery: A Subgroup Analysis of the Meta-Analysis of Chemotherapy in Head and Neck Cancer.” Oral Oncology 95 (August 2019): 106–14. https://doi.org/10.1016/j.oraloncology.2019.06.001.
Mouly, Laetitia, Julia Gilhodes, Anthony Lemarié, Elizabeth Cohen-Jonathan Moyal, Christine Toulas, Gilles Favre, Olivier Sordet, and Sylvie Monferran. “The RND1 Small GTPase: Main Functions and Emerging Role in Oncogenesis.” International Journal of Molecular Sciences 20, no. 15 (July 24, 2019). https://doi.org/10.3390/ijms20153612.
Modesto, A., C. Chira, J.-C. Sol, V. Lubrano, S. Boulinguez, C. Pagès, V. Sibaud, C. Gomez-Roca, É Moyal, and N. Meyer. “[Treatment of patients with brain metastases from a melanoma].” Cancer Radiotherapie: Journal De La Societe Francaise De Radiotherapie Oncologique 23, no. 2 (April 2019): 147–50. https://doi.org/10.1016/j.canrad.2018.05.006.
Kowalski-Chauvel, Aline, Valerie Gouaze-Andersson, Laurent Baricault, Elodie Martin, Caroline Delmas, Christine Toulas, Elizabeth Cohen-Jonathan-Moyal, and Catherine Seva. “Alpha6-Integrin Regulates FGFR1 Expression through the ZEB1/YAP1 Transcription Complex in Glioblastoma Stem Cells Resulting in Enhanced Proliferation and Stemness.” Cancers 11, no. 3 (March 22, 2019). https://doi.org/10.3390/cancers11030406.
Laprie, Anne, Soléakhéna Ken, Thomas Filleron, Vincent Lubrano, Laure Vieillevigne, Fatima Tensaouti, Isabelle Catalaa, et al. “Dose-Painting Multicenter Phase III Trial in Newly Diagnosed Glioblastoma: The SPECTRO-GLIO Trial Comparing Arm A Standard Radiochemotherapy to Arm B Radiochemotherapy with Simultaneous Integrated Boost Guided by MR Spectroscopic Imaging.” BMC Cancer 19, no. 1 (February 21, 2019): 167. https://doi.org/10.1186/s12885-019-5317-x.
De Barros, Amaury, Justine Attal, Margaux Roques, Julien Nicolau, Jean-Christophe Sol, Elizabeth Cohen-Jonathan-Moyal, and Franck-Emmanuel Roux. “Impact on Survival of Early Tumor Growth between Surgery and Radiotherapy in Patients with de Novo Glioblastoma.” Journal of Neuro-Oncology, February 19, 2019. https://doi.org/10.1007/s11060-019-03120-3.
Malric, Laure, Sylvie Monferran, Caroline Delmas, Florent Arnauduc, Perrine Dahan, Sabrina Boyrie, Pauline Deshors, et al. “Inhibiting Integrin Β8 to Differentiate and Radiosensitize Glioblastoma-Initiating Cells.” Molecular Cancer Research: MCR 17, no. 2 (2019): 384–97. https://doi.org/10.1158/1541-7786.MCR-18-0386.

LES MEMBRES DE L’ÉQUIPE

Emma Huard
Master / Master student
Gaelle Dormio
Ingénieur de laboratoire / laboratory engineer
Lucas Robinet
Doctorant / PhD student
Ziad Kheil
Doctorant / PhD student
Augustin Le Naour
Enseignant chercheur / University researcher
Anouchka Modesto
Clinicien Chercheur / Researcher hospital practitioner
Emmanuelle Uro-Coste
Hospitalo-Universitaire / University teacher hospital practitioner
Luc Simon
Clinicien Chercheur / Researcher hospital practitioner
Solène Evrard
Enseignant chercheur / University researcher
Laurent Baricault
Enseignant chercheur / University researcher
Anthony Lemarié
Enseignant chercheur / University researcher
Monique Courtade-Saïdi
Hospitalo-Universitaire / University teacher hospital practitioner
Elizabeth Moyal
Hospitalo-Universitaire / University teacher hospital practitioner
Laure Vieillevigne
Enseignant chercheur / University researcher
Tom Maillet
Doctorant / PhD student
Alexia Delbaere
Chercheur statutaire / permanent scientist
Valérie Gouaze-Andersson
Chercheur statutaire / permanent scientist
Sheraz Blas
Doctorant / PhD student
Pauline Deshors
Chercheur Post-Doctorant / Post-Doc researcher
Yvan Nicaise
Ingénieur de laboratoire / laboratory engineer

LES PARTENAIRES & FINANCIERS

Centre de Recherches en Cancérologie de Toulouse

Centre de Recherches en Cancérologie de Toulouse (Oncopole)

Toulouse – FR

Nous contacter

05 82 74 15 75

Envie de rejoindre
L’équipe du CRCT ?

Pin It on Pinterest